MetLife Investment Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,926
Closed -$105K 2809
2024
Q4
$105K Buy
2,926
+1,569
+116% +$81.2K ﹤0.01% 2602
2024
Q3
$64.1K Sell
1,357
-1,266
-48% -$55.9K ﹤0.01% 2728
2024
Q2
$132K Buy
2,623
+627
+31% +$45.3K ﹤0.01% 2469
2024
Q1
$224K Buy
1,996
+130
+7% +$12.9K ﹤0.01% 2140
2023
Q4
$108K Hold
1,866
﹤0.01% 2573
2023
Q3
$59.2K Hold
1,866
﹤0.01% 2804
2023
Q2
$153K Hold
1,866
﹤0.01% 2425
2023
Q1
$192K Hold
1,866
﹤0.01% 2250
2022
Q4
$273K Hold
1,866
﹤0.01% 2048
2022
Q3
$315K Buy
1,866
+326
+21% +$53K ﹤0.01% 1982
2022
Q2
$178K Buy
1,540
+541
+54% +$50.9K ﹤0.01% 2401
2022
Q1
$99.6K Sell
999
-82
-8% -$9.58K ﹤0.01% 2626
2021
Q4
$168K Buy
1,081
+386
+56% +$75.1K ﹤0.01% 2166
2021
Q3
$164K Sell
695
-338
-33% -$98.7K ﹤0.01% 2206
2021
Q2
$351K Buy
1,033
+187
+22% +$70.8K ﹤0.01% 1790
2021
Q1
$342K Sell
846
-71
-8% -$34.4K ﹤0.01% 1741
2020
Q4
$610K Hold
917
0.01% 1380
2020
Q3
$427K Buy
917
+86
+10% +$43.5K ﹤0.01% 1450
2020
Q2
$486K Buy
831
+97
+13% +$33.1K 0.01% 1396
2020
Q1
$107K Buy
+734
New +$128K ﹤0.01% 2035

Other funds holding MRSN